voglibose 03 mg metformin sr 1000

Introduction

VOGLIGOLD M 0.3 is a combination medication primarily used in the management of Type 2 diabetes mellitus. The drug combines Voglibose (0.3 mg), an alpha-glucosidase inhibitor, with Metformin Hydrochloride SR (500 mg), a widely used oral hypoglycemic agent in diabetes care. This combination aims to provide effective blood sugar control by targeting different mechanisms in the body, reducing both postprandial (after-meal) and fasting blood glucose levels.

Type 2 diabetes mellitus is a chronic condition that affects the body's ability to metabolize glucose properly. It is characterized by insulin resistance, decreased insulin secretion, and an increased rate of glucose production by the liver. Managing diabetes requires a multifaceted approach involving lifestyle modifications, diet, exercise, and medications such as VOGLIGOLD M 0.3. This medication is typically prescribed when diet and exercise alone are not sufficient to control blood sugar levels.

This article explores the key ingredients, mechanisms of action, benefits, uses, dosage instructions, potential side effects, and other important aspects of VOGLIGOLD M 0.3.

Key Ingredients

1. Voglibose (0.3 mg)
Voglibose is an alpha-glucosidase inhibitor used in the treatment of diabetes. It works by inhibiting the activity of enzymes (alpha-glucosidases) in the small intestine that are responsible for breaking down complex carbohydrates into simple sugars. By slowing down the breakdown and absorption of carbohydrates, Voglibose helps to control postprandial blood glucose levels, which typically rise after eating. This can help prevent sharp spikes in blood sugar after meals and improve overall blood glucose control.

2. Metformin Hydrochloride SR (500 mg)
Metformin is a biguanide class of medication and one of the most commonly prescribed drugs for the treatment of Type 2 diabetes. It works by improving insulin sensitivity in the body, particularly in the liver and muscles, thus enhancing the body's ability to utilize glucose. Additionally, Metformin helps to decrease hepatic glucose production (the amount of glucose released by the liver). In Metformin Hydrochloride SR (Sustained Release) form, the drug is released slowly into the bloodstream, leading to more consistent blood sugar control throughout the day with a lower risk of side effects.

Key Benefits

1. Improved Blood Sugar Control
   The combination of Voglibose and Metformin provides a synergistic effect in controlling blood sugar. Voglibose primarily controls postprandial blood sugar levels, while Metformin regulates both fasting blood sugar levels and overall glucose metabolism. Together, they help maintain stable blood sugar levels throughout the day, reducing the risk of both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar).

2. Reduction of Postprandial Hyperglycemia
   One of the major advantages of VOGLIGOLD M 0.3 is its ability to reduce postprandial hyperglycemia. After a meal, the body normally breaks down carbohydrates into glucose, which enters the bloodstream, leading to an increase in blood sugar levels. By inhibiting the breakdown of carbohydrates, Voglibose prevents these sharp increases in blood sugar.

3. Sustained Release Formula
   Metformin Hydrochloride SR helps maintain consistent blood glucose control by releasing the medication slowly over time. This minimizes the risk of side effects like stomach upset and improves patient adherence to the treatment regimen by reducing the frequency of administration (compared to immediate-release forms).

4. Reduced Insulin Resistance
   Metformin, as a part of this combination, plays a crucial role in improving insulin sensitivity. By reducing insulin resistance, the body can utilize glucose more efficiently, thus lowering blood sugar levels.

5. Weight Management
   Unlike some other diabetes medications that promote weight gain, Metformin is known to help with modest weight reduction or, at the very least, maintain a stable weight. It is often preferred for overweight or obese diabetic patients.

How Does It Work?

VOGLIGOLD M 0.3 works through the combined action of its two active ingredients, Voglibose and Metformin Hydrochloride SR, each targeting different aspects of glucose metabolism in the body.

• Voglibose works by inhibiting alpha-glucosidase enzymes in the small intestine. These enzymes are responsible for breaking down complex carbohydrates into glucose. By slowing down carbohydrate digestion and absorption, Voglibose prevents sharp increases in postprandial blood glucose levels, leading to better overall glucose control after meals.

• Metformin Hydrochloride SR works by:

  • Reducing the amount of glucose produced by the liver.
  • Increasing insulin sensitivity in the body's tissues (mainly muscle and fat cells).
  • Slowing down the absorption of glucose in the intestines.
  • Helping in weight management by reducing appetite and fat accumulation.

Together, these two components provide a comprehensive approach to managing Type 2 diabetes by controlling blood sugar levels both during fasting and after meals.

Uses of VOGLIGOLD M 0.3

1. Type 2 Diabetes Mellitus
VOGLIGOLD M 0.3 is primarily used in the management of Type 2 diabetes mellitus, especially when diet and exercise are insufficient to maintain optimal blood glucose levels. It is often prescribed when other oral medications like sulfonylureas or thiazolidinediones fail to provide adequate control over blood sugar levels.

2. Postprandial Hyperglycemia
Patients with elevated blood sugar levels after meals can benefit significantly from the inclusion of Voglibose in this combination therapy. By preventing rapid absorption of glucose after eating, VOGLIGOLD M 0.3 helps mitigate the spikes in blood glucose that can contribute to long-term complications of diabetes.

3. Insulin Resistance
For patients with Type 2 diabetes who experience insulin resistance, Metformin in VOGLIGOLD M 0.3 can improve insulin sensitivity, making it easier for the body to use insulin and manage glucose effectively.

Dosage and Administration

VOGLIGOLD M 0.3 should be taken as per the prescribed dosage by a healthcare professional. Typically, it is recommended to take the medication with meals to reduce gastrointestinal side effects and enhance its effectiveness in controlling postprandial glucose spikes.

• Typical Dosage:

  • Adults: The usual dosage is one tablet (containing Voglibose 0.3 mg + Metformin Hydrochloride SR 500 mg) taken once or twice daily with meals. The dosage may vary depending on the patient's blood glucose levels, individual response to the medication, and the presence of other health conditions.
  • Titration: In some cases, the dose may be gradually increased, starting from a lower dose, to avoid gastrointestinal discomfort.

• Administration:
  The tablet should be swallowed whole with water and not crushed or chewed to ensure proper release of the sustained-release formulation.

Side Effects

While VOGLIGOLD M 0.3 is generally well-tolerated, there are potential side effects that patients should be aware of. These include:

1. Gastrointestinal Issues:

   • Metformin can cause nausea, vomiting, diarrhea, and abdominal discomfort, especially in the initial stages of treatment. This can be minimized by starting with a low dose and taking the medication with meals.
   • Voglibose may also cause flatulence, bloating, or diarrhea due to its action on carbohydrate absorption.

2. Hypoglycemia:

   • Although VOGLIGOLD M 0.3 itself does not cause significant hypoglycemia (low blood sugar), when combined with other medications (such as insulin or sulfonylureas), the risk of hypoglycemia may increase. Patients should monitor their blood sugar levels regularly.

3. Lactic Acidosis:

   • A rare but serious side effect of Metformin is lactic acidosis, a condition where lactic acid builds up in the bloodstream. This is more likely in patients with kidney problems, liver disease, or alcohol use disorders. Symptoms include unusual muscle pain, trouble breathing, dizziness, and fatigue. Immediate medical attention is necessary.

4. Vitamin B12 Deficiency:

   • Long-term use of Metformin has been associated with reduced absorption of Vitamin B12. Regular monitoring of B12 levels is recommended for patients on prolonged treatment.

5. Weight Loss:

   • Some patients may experience mild weight loss, which can be beneficial for obese individuals with Type 2 diabetes, although this is not guaranteed for all users.

Price and Availability

The cost of VOGLIGOLD M 0.3 varies based on the country, manufacturer, and distribution channels. It is typically available in local pharmacies, and prices may differ between generic and branded versions. It is important to check with a healthcare provider or pharmacist for specific pricing information.

Conclusion

VOGLIGOLD M 0.3 combines the power of Voglibose and Metformin Hydrochloride SR to provide comprehensive blood sugar control in patients with Type 2 diabetes mellitus. By targeting different mechanisms in the body, this combination therapy helps control both fasting blood glucose and postprandial glucose levels. It is particularly useful for patients who require more than just lifestyle modifications to manage their diabetes effectively.

As with any medication, it is important to follow the prescribed dosage and monitor for potential side effects. Patients should also maintain regular follow-ups with their healthcare provider to ensure optimal diabetes management and minimize complications.

VOGLIGOLD M 0.3 is a reliable choice in the multifaceted approach to managing Type 2 diabetes, supporting patients in leading healthier, more balanced lives.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW